Showing results (1-10 of 4,979) with videos related to
Sort By:
Pageof 498
Medical Oncology (Northwood, London, England)|July 2, 2014
MicroRNA-21 and multiple myeloma: small molecule and big functionJing Ma, Su Liu, Yafei WangAnnals of Medicine|April 12, 2024
Myeloid neoplasms post cytotoxic therapy: epidemiology, pathogenesis outcomes, prognostic factors, and treatment optionsJing Ma, Yafei WangCarcinogenesis|November 25, 2022
DUT enhances drug resistance to proteasome inhibitors via promoting mitochondrial function in multiple myelomaYafei Wang, Shuang Gao, Lin Chen, et al.Frontiers in Oncology|January 24, 2022
Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor in Multiple MyelomaYafei Wang, Lin Chen, Qian Li, et al.Leukemia Research|August 13, 2016
IRE1α-XBP1 signaling pathway, a potential therapeutic target in multiple myelomaLin Chen, Qian Li, Tiantian She, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 12, 2018
Ibrutinib targets microRNA-21 in multiple myeloma cells by inhibiting NF-κB and STAT3Jing Ma, Wei Gong, Su Liu, et al.International Journal of Clinical and Experimental Pathology|September 9, 2014
Clinical characteristics of 26 patients with primary extranodal Hodgkin lymphomaJing Ma, Yafei Wang, Haifeng Zhao, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 3, 2015
[The clinical and pathological characteristics of 14 patients' nodular lymphocyte predominant Hodgkin's lymphoma]Su Liu, Jing Ma, Yuanfang Yue, et al.Oncotargets and Therapy|May 24, 2019
Multiple myeloma with dural mater involvementSu Liu, Xubin Li, Yueyang Li, et al.Neoplasia (New York, N.Y.)|March 9, 2025
HRP2 regulating MICU1-mediated Ca2+ overload to dictate chemoresistance of multiple myelomaQian Li, Ziyi Peng, Li Lin, et al.Pageof 498